1. Home
  2. RDHL vs FEED Comparison

RDHL vs FEED Comparison

Compare RDHL & FEED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Redhill Biopharma Ltd.

RDHL

Redhill Biopharma Ltd.

N/A

Current Price

$0.85

Market Cap

4.0M

Sector

Health Care

ML Signal

N/A

FEED

ENvue Medical Inc. Common Stock

N/A

Current Price

$47.34

Market Cap

4.3M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
RDHL
FEED
Founded
2009
2003
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0M
4.3M
IPO Year
2012
2014

Fundamental Metrics

Financial Performance
Metric
RDHL
FEED
Price
$0.85
$47.34
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.1M
296.6K
Earning Date
04-27-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$318,000.00
Revenue This Year
$381.91
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$0.29
52 Week High
$2.79
$6.09

Technical Indicators

Market Signals
Indicator
RDHL
FEED
Relative Strength Index (RSI) 68.84 96.25
Support Level $0.76 $0.96
Resistance Level $0.91 $6.09
Average True Range (ATR) 0.09 0.08
MACD 0.04 0.23
Stochastic Oscillator 28.43 89.76

Price Performance

Historical Comparison
RDHL
FEED

About RDHL Redhill Biopharma Ltd.

RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.

About FEED ENvue Medical Inc. Common Stock

ENvue Medical Inc is a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings. It focuses on two technology platforms: the ENvue Navigation Platform, which provides an electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract; FDA 510(k) cleared for adult use, it provides real-time bedside visualization of tube movement and supports informed decision-making during the placement procedure. Its Medical advances non-invasive therapy and minimally invasive navigation, with a commitment to patient safety, clinical usability, and technology innovation in healthcare environments, and the company's acoustic-based therapeutic technologies.

Share on Social Networks: